| Name |
Recombinant Human LILRA1/CD85i/LIR-6 Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9226-T4
|
| Category |
Protein
|
| Prices |
$339.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Mouse myeloma cell line, NS0-derived Pro17-Asn461, with a C-terminal 6-His tag
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA1/CD85i/LIR-6 (Catalog # 9226-T4) is coated at 2 µg/mL, Recombinant Human Angiopoietin-like 7/ANGPTL7 (Catalog # 914-AN ) binds with an ED 50 = 0.3-1.8 µg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
O75019
|
| Gene |
LILRA1
|
| Sequence |
Pro17 & Gly24
|
| Supplier Page |
Shop
|
WhenRecombinant Human LILRA1/CD85i/LIR-6 (Catalog # 9226-T4) is coated at 2 µg/mL,Recombinant Human Angiopoietin-likeProtein 7/ANGPTL7 (Catalog # 914-AN ) binds with anED 50 of 0.3-1.8 µg/mL.